Figures & data
Figure 1 ZD55-IL-18 plus DTIC exhibited synergistic effects in the inhibition of A375 cell viability.
Abbreviations: DTIC, dacarbazine; IL-18, interleukin-18.
![Figure 1 ZD55-IL-18 plus DTIC exhibited synergistic effects in the inhibition of A375 cell viability.](/cms/asset/66c391d6-bcb2-4090-b0cc-10ff587abe45/dddt_a_12173077_f0001_b.jpg)
Figure 2 ZD55-IL-18 drove E1A and IL-18 expression in A375 cells.
Abbreviations: DTIC, dacarbazine; IL-18, interleukin-18; PBS, phosphate-buffered saline.
![Figure 2 ZD55-IL-18 drove E1A and IL-18 expression in A375 cells.](/cms/asset/e646f34e-cbd0-4349-9121-e05b96547138/dddt_a_12173077_f0002_b.jpg)
Figure 3 ZD55-IL-18 and DTIC increased apoptosis of A375 cells.
Abbreviations: DTIC, dacarbazine; PBS, phosphate-buffered saline; IL-18, interleukin-18.
![Figure 3 ZD55-IL-18 and DTIC increased apoptosis of A375 cells.](/cms/asset/0f82d7b2-deea-4412-8366-b982354ebaad/dddt_a_12173077_f0003_c.jpg)
Figure 4 ZD55-IL-18 and DTIC demonstrated synergistic antitumor effects in melanoma A375 mouse xenografts.
Abbreviations: DTIC, dacarbazine; IL-18, interleukin 18; PBS, phosphate-buffered saline; w, weeks.
![Figure 4 ZD55-IL-18 and DTIC demonstrated synergistic antitumor effects in melanoma A375 mouse xenografts.](/cms/asset/4ed36400-cef1-4b24-a974-e1c206a7aaa9/dddt_a_12173077_f0004_c.jpg)
Figure 5 ZD55-IL-18 and DTIC demonstrated synergistic effects to induce apoptosis and upregulate VEGF expression in melanoma mouse xenografts.
Abbreviations: DTIC, dacarbazine; VEGF, vascular endothelial growth factor; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labeling; dUTP, 2′-deoxyuridine-5′-triphosphate; HE, hematoxylin and eosin; PBS, phosphate-buffered saline; IL-18, interleukin-18.
![Figure 5 ZD55-IL-18 and DTIC demonstrated synergistic effects to induce apoptosis and upregulate VEGF expression in melanoma mouse xenografts.](/cms/asset/c1015394-74c9-4b22-83c0-32a16049a1b0/dddt_a_12173077_f0005_c.jpg)